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Abstract
Background: The physiological function of the prion protein remains largely elusive while its key role in prion infection 
has been expansively documented. To potentially assess this conundrum, we performed a comparative transcriptomic 
analysis of the brain of wild-type mice with that of transgenic mice invalidated at this locus either at the zygotic or at 
the adult stages.
Results: Only subtle transcriptomic differences resulting from the Prnp knockout could be evidenced, beside Prnp itself, 
in the analyzed adult brains following microarray analysis of 24 109 mouse genes and QPCR assessment of some of the 
putatively marginally modulated loci. When performed at the adult stage, neuronal Prnp disruption appeared to 
sequentially induce a response to an oxidative stress and a remodeling of the nervous system. However, these events 
involved only a limited number of genes, expression levels of which were only slightly modified and not always 
confirmed by RT-qPCR. If not, the qPCR obtained data suggested even less pronounced differences.
Conclusions: These results suggest that the physiological function of PrP is redundant at the adult stage or important 
for only a small subset of the brain cell population under classical breeding conditions. Following its early reported 
embryonic developmental regulation, this lack of response could also imply that PrP has a more detrimental role 
during mouse embryogenesis and that potential transient compensatory mechanisms have to be searched for at the 
time this locus becomes transcriptionally activated.
Background
The pivotal role that the prion protein (PrP) plays in
transmissible spongiform encephalopathies (TSE) is now
well established [[1,2] for recent reviews]. The conversion
of this host-encoded protein to an abnormal, partially
proteinase K resistant, isoform is a hallmark of most TSEs
and PrP is the only known constituent of mammalian pri-
ons [3]. The Prnp gene that encodes for PrP, is expressed
in a broad range of vertebrate tissues but most abun-
dantly in the central nervous system [4].
Although PrP is evolutionary conserved, suggesting
that it has an important role, its physiological function
remains unclear even though its implication in neuropro-
tection, response to oxidative stress, cell proliferation and
differentiation, synaptic function and signal transduction
has been proposed [5,6]. Its temporal regulation led also
to suspect an implication of this protein in early embryo-
genesis [7-9] but Prnp-knockout mice [10,11], cattle [12]
and goat [13] were obtained with no drastic developmen-
tal phenotype and only subtle alterations of their circa-
dian rhythm, hippocampal function and of their behavior.
A similar observation was made when this gene was
invalidated in adult neurons [14,15]. To explain these
data, it was hypothesized that another host-encoded pro-
tein is able to compensate for the lack of PrP [16]. How-
ever, this protein has not yet been identified.
Transcriptomic analysis has emerged as a powerful tool
to decipher cellular pathways that are modified following
a gene expression alteration as it does not pre-require the
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need of restricting hypothesis. Such approaches have
been conducted to analyze the mechanisms underlying
prion replication and neurotoxicity [see [17-24] for recent
examples]. The obtained results appeared however
inconsistent and closely related to the cell type and/or
strain and animal model used, leading to difficulties in
identifying the metabolic pathways involved.
Fewer studies have used a similar approach to try to
understand the biological function of the PrP protein in
immortalized non-neuronal cells [25-27]. The obtained
results appear again to correlate with the cell line used as
experimental model and no shared pathway has emerged
from the comparison of these different experiments. In
parallel, proteomic studies have been conducted either
using two cell lines [28] or transgenic knockout mice [29].
While different sets of proteins were found to be affected
by the PrP expression level in cells according to their ori-
gin, no significant difference was detected in the brain
proteome of the analyzed 129/Sv-C57/Bl6 transgenic
mice, bearing in mind that variations occurring for low
abundant proteins might not have been detected [29].
In the present study, we report the comparisons of the
whole brain transcriptomes of PrP knockout or wild type
mice, both on an FVB/N genetic background, and of that
of mice invalidated for the Prnp locus in adult neurons.
Results and Discussion
Comparative transcriptional analysis of FVB/N versus FVB/
N Prnp-/- mouse brains
A search for differentially expressed genes was done by
comparison of the expression profiles of FVB/N versus
FVB/N Prnp-/- [10,30] mouse brains. To this aim, RNA
samples were prepared by pooling RNAs from 5 brains of
6-week old mice of each genotype. After statistical analy-
sis, two genes were found to be differentially expressed,
including the Prnp one (Table 1). The relatively low log
ratio observed for the variation in Prnp  expression is
explained by the fact that the knockout experiment was
done in such a way that the gene remains expressed
although at a lower level, around 2 to 3 fold, as observed
by Northern blotting (data not shown), but that the
resulting mRNA does not encode for PrP anymore [10].
QPCR was applied to confirm the suspected differential
expression of the detected genes using the same pools of
brain RNAs. Both Prnp and Scg5 differential expression
were confirmed (Table 1). The higher relative fold-change
observed by QPCR for the Prnp gene compared to that
detected in the micro-array experiment is related to the
location of the used primers in exon 2 and in exon 3 of the
PrP-encoding gene respectively, which will not amplify
the retro-transcribed RNA expressed by the invalidated
locus.
The  Scg5  encodes the 7B2 neuroendocrine secretory
protein, a specific chaperone for the proprotein con-
vertase 2 [31]. Invalidation of this gene leads to a hyperse-
cretion of cortocitropin that induces early lethality. This
protein function was of interest in regards with PrP since
hypercorticism is a phenotype associated with scrapie in
ewes [32]. However, a search in the mouse genome data-
base for the chromosomal localization of the Prnp and
Scg5  loci revealed that these two genes are physically
linked and only 11 cM apart. It has been reported that the
level of expression of 7B2, at least in the pancreas, differs
between mouse strains and is related to a genetic poly-
morphism that occurs within its proximal promoter [33].
Since the Prnp knockout was done on 129/Sv ES cells, we
hypothesized that the Scg5 gene could still be of a 129/Sv
genetic origin in FVB/N Prnp-/- mice while it is of FVB/N
genetic origin in wild-type mice. We amplified by PCR
and sequenced the -200/-60 Scg5 promoter region start-
ing from genomic DNA of three FVB/N, 129/Sv and
FVB/N  Prnp-/-  mice, respectively. A single nucleotide
Table 1: Candidate genes resulting from microarray studies comparing FVB/N Prnp-/- versus FVB/N mice.
Genes FVB/N Prnp-/- FVB/N Prnp-/- Protein
Microarray QPCR
(Log2 ratio) (ΔΔ CT)
Downregulated
Prnp -1.63 -15 Prion protein or PrPc
Scg5 -1.37 -2.13 Neuroendocrine secretory protein 7B2
Upregulated
None
Differentially expressed genes detected by the microarray analysis are listed with the calculated differential ratio (log2) alongside the 
observed delta-delta CT resulting from the QPCR experiment. The comparative Ct method is known as the 2 [delta][delta]Ct method, where delta 
delta Ct = [delta]Ct, sample - [delta]Ct, referenceChadi et al. BMC Genomics 2010, 11:448
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polymorphism (G/T) could be detected at position -97
that discriminates between the FVB/N and the 129/Sv or
FVB/N Prnp-/- genotypes (Table 2). These results thus
indicate that in the FVB/N Prnp-/- mice, the Scg5 locus
remains of 129/Sv genetic origin. It is worth mentioning
that the detected single nucleotide polymorphism abol-
ishes a putative AML 1A transcription factor binding site,
TGGGGT, in the FVB/N Scg5 promoter possibly explain-
ing the different levels of expression observed. Alto-
gether, these data suggest that the brain Scg5 differential
expression between the FVB/N and FVB/N Prnp-/- mice
results from a different genetic origin of this locus.
The observed poor transcriptional alteration in the
brain of mouse depleted for PrP could suggest that these
animals adapted to this genetic environment during
embryogenesis. If such, invalidation of the PrP-encoding
gene at an adult stage might induce detectable transient
modification of the genome transcriptomic regulation.
Using already validated conditional knockout transgenic
lines [14], we analyzed the potential impact of an adult
neuronal PrP depletion on the overall brain transcrip-
tome.
Incidence of a post-natal neuronal PrP depletion on the 
brain transcriptome
This experiment was performed using Tg37 mice, trans-
genic mice expressing physiological levels of mouse PrP
from a transgene composed of a the floxed coding
sequences inserted within the hamster-based CosShaTet
expression vector, crossed with NFH-Cre transgenic mice
[14]. Both transgenic mice were under a mouse Prnp-
knockout genetic background. The brain RNA pools con-
sisted of littermates of 2 males and 2 females of either 10
or 14 weeks old for each Tg37+/- NFH-Cre-/- or Tg37+/-
NFH-Cre+/- genotypes. These two ages were chosen since
activation of the NFH promoter results in ablation of PrP
in neurons after 9 weeks [14]. After statistical analysis, 11
and 47 genes were found to be differentially expressed at
10 (Table 3) or 14 (Table 4) weeks, respectively. At 10
weeks, 3 genes were over-expressed and 8 under-
expressed in Prnp depleted mice as compared with the
NFH-Cre-negative control animals. At 14 weeks, 21 and
26 genes were over-expressed or under-expressed,
respectively. Because the oligonucleotide that recognized
Prnp in the microarray is located within the 3' UTR of the
gene, a region poorly conserved, it was not expected to
detect expression of the Tg37 transgene that encom-
passes the hamster Prnp 3'UTR sequence and indeed dif-
ferential expression of this gene was not revealed. The
absence of the Scg5 locus within the detected differen-
tially expressed genes further supports the above hypoth-
esis that explains its detection in the previous experiment
by a physical link between the Scg5 and the Prnp loci
rather than by a functional one.
QPCR was applied to confirm the microarray results
for the genes suspected differentially expressed with the
observed highest log2 ratios, using the same pools of
brain RNAs and to assess the Cre-induced Prnp invalida-
tion (Table 5). This latter point was confirmed at both 10
and 14 weeks with a highly significant knockdown of the
Tg37-transgene expression in the brain of Tg37-NFH-Cre
transgenic mice. The down-regulation observed is less
important than that detected in FVB/N Prnp-/-  mice
which is an expected result since the Cre deletion is lim-
ited to the neurons, due to the tissue-specificity of the
NFH promoter. The slight difference observed between
10 and 14 weeks might suggest that at 10 weeks, the dele-
tion process is not fully complete. The percentage of
brain cells that have a deleted Tg37 transgene following
Cre activation was previously estimated to be around 29 -
37% [14]. Our data suggest that these cells are among
those that express the transgene the most.
The microarray data were confirmed for 5 out of 9 ana-
lyzed genes (Table 5). Among the non-confirmed genes is
the above mentioned AV451297.1 putative gene. This
gene, located in mouse chromosome 17 and/or mouse
chromosome 6, encodes for a hypothetical protein, and
its transcription was only reported as an EST in ES cells.
The non-confirmation of the differential expression of
this gene was surprising since its estimated log ratio was
relatively high. Blast alignment of the microarray oligonu-
cleotide corresponding to this gene allowed us to design
p r i m e r s  t h a t  r e c o g n i z e d  a  f a m i l y  o f  m o u s e  E S T s  t h a t
encompass this sequence (Table 6). However, this oligo-
nucleotide aligns with various regions of the mouse
genome (data not shown), located on several chromo-
Table 2: Single nucleotide polymorphism observed within the Scg5 proximal promoter region.
...-111 -87....
FVB/N ....CAGGGCTTAAGTGCGGGGGTAGGAAA
FVB/N Prnp-/- ....CAGGGCTTAAGTGC TGGGGTAGGAAA
129 ....CAGGGCTTAAGTGC TGGGGTAGGAAA
The sequences were obtained from three independent mice of each genotype. The sequences are numbered backward starting from the 
reported distal-most transcription initiation site [33]. The observed single nucleotide polymorphism is indicated in bold-faced type.Chadi et al. BMC Genomics 2010, 11:448
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somes, and we therefore cannot exclude that a transcript,
originating from one of these regions, that will not be
amplified by our set of primers is responsible for the
observed differential expression. Although showing a
down-regulated expression in Tg37+/- NFH-Cre+/- mice in
both the micro-array analysis and the QPCR experiment,
the ratio observed by QPCR was relatively lower than
could be expected for the ifitm3 gene. The primers used
for the QPCR were chosen in order not to amplify the
other  ifitm  gene family mRNAs (see Table 6 for the
QPCR primer sequences). However, they share some
homology with the ankyrin repeat domain 12 (data not
shown) which might interfere with the obtained results.
The other non-confirmed genes correspond to differen-
tially expressed genes showing very low log2 ratios on the
microarray results, between -0.8 and + 0.8. Overall the
qPCR obtained data for these genes strengthen the rela-
tive transcriptomic stability of the Prnp knockout brain.
The microarray and QPCR data were consistent for the
Erf1  transcriptional deregulation (Table 5). We further
analyzed the expression level of this gene in the brain of
Prnp-knockout mice expressing or not the NFH-Cre
transgene. No difference was observed (data not shown),
demonstrating that the Cre expression does not signifi-
cantly influence the expression profile of this locus and
thus that its observed deregulation in our experiment
results from the Prnp invalidation. Although we cannot
formally exclude that some of the other deregulated genes
listed in Tables 3 and 4 results from the Cre expression,
this data strongly suggest that the neuronal PrP depletion
is responsible for the observed transcriptional modifica-
tions.
The log ratios observed for the other detected differen-
tially expressed genes were relatively low. However, it has
to be kept in mind that this invalidation only involved
neuronal cells, and probably not all of them [14], and thus
that transcriptomic modifications occurring within this
cell population will be diluted by the heterogeneous cell
composition of the analyzed adult brain tissues. It could
also suggest that the biological relevance of the observed
variation is doubtful. Only 3 genes were found to be dif-
ferentially expressed at both stages, Kcnj5, 1810030J14Rik
and Synaptotagmin 11 (Tables 3 and 4), of which only
1810030J14Rik  was found to behave similarly between
these two time-points. This apparent discrepancy could
be explained when the function of the differentially
express genes was further analyzed, either using the Inge-
nuity pathways analysis or by looking at the expression
pattern and putative functions attributed to those genes
(Tables 3 and 4). At 10 weeks, the detected genes appear
to reflect a cellular response to an oxidative stress (Table
3), which is in phase with putative physiological functions
attributed to PrP [5,6]. Some of the detected genes also
suggest that at that stage, the PrP depletion might induce
damaged synaptic trafficking and cell death, two cellular
pathways into which PrP is also suspected to have a role
Table 3: Differentially expressed genes detected at 10 weeks by microarray studies comparing Tg37+/- NFH-Cre-/- and 
Tg37+/- NFH-Cre+/- brain tissues.
Microarray ID Locus Name Ratio (log2) Bonf Pval Top Functions
301955 Atp13a1 0,81 2,90E-09 Response to oxidative stress
217673 A630023P12Rik -0,62 3,16E-04 Unknown
250792 Txnl2 -0,60 8,65E-04 Cardiovascular system development, Neuronal 
differentiation
262559 Zfp819 -0,58 2,89E-03 Embryonic Development
203516 Sepx1 -0,56 7,29E-03 Genetic Disorder
284620 Slc8a1 -0,54 1,74E-02 Response to oxidative stress
235326 Kcnj5 -0,54 2,31E-02 Cell Death, Neurological Disease, Nervous System 
Development and Function
202068 1810030J14Rik -0,53 3,99E-02 Cancer, Cell death
268919 A130070M06 -0,52 4,95E-02 Ribosome release
253726 Synaptotagmin11 0,52 4,38E-02 Synaptic vesicle trafficking, Nervous system function, 
Response to oxidative Stress
247145 0610038F07Rik 0,58 3,43E-03 Mitochondrial function
Differentially expressed genes detected by the microarray analysis are listed with the calculated differential ratios (log2) and the Bonferroni 
p values (Bonf Pval). The top functions were deduced either using the Ingenuity pathways analysis software http://www.ingenuity.com or by 
looking at the expression pattern and putative functions attributed to those genes (italized annotations). Italic names: genes potentially 
involved in cellular development and differentiation. Bold-faced type names: genes potentially involved in cell death and disorders, including 
response to oxidative stress. Italic and bold-faced type names: genes potentially involved in both sets of functions.Chadi et al. BMC Genomics 2010, 11:448
http://www.biomedcentral.com/1471-2164/11/448
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Table 4: Differentially expressed genes detected at 14 weeks by microarray studies comparing Tg37+/- NFH-Cre-/- and 
Tg37+/- NFH-Cre+/- brain tissues.
Microarray ID Locus Name Ratio (log2) Bonf Pval Top Functions
275404 EST1 (Genebank AV451297.1) -2,62 0,00E+00 Unknown (Embryonic Development)
197253 Ifitm3 -1,41 0,00E+00 DNA replication, Nervous System 
Development and Function
237827 AY036118 -1,19 0,00E+00 Eukaryotic polypeptide chain releasing factor
245680 4931406E20Rik -0,92 0,00E+00 Unknown
202068 1810030J14Rik -0,89 0,00E+00 Unknown (Cancer, Cell death)
196280 Prelid2 -0,81 1,40E-10 Cardiovascular Disease, Cellular 
Development, Embryonic Development
211028 4930428E07Rik -0,79 6,77E-10 Unknown (Reproductive System)
272796 6430604K15Rik -0,76 7,67E-09 Unknown (Zinc Finger protein)
312533 BM229693 -0,71 2,99E-07 Unknown (Embryonic Development)
231366 Tmem98 -0,69 7,27E-07 Unknown (Transmembrane protein)
242062 Sdccag3 -0,65 1,11E-05 Cancer, Cardiovascular System 
Development and Function, Reproductive 
system Disease
226542 Ifng -0,62 6,35E-05 Cardiovascular Disease, Cellular 
Development, Embryonic Development 
Cell Death, Neurological Disease, Nervous 
System
281732 Papss2 -0,60 1,62E-04 Development and Disease Cell Death, 
Neurological Disease, Nervous System
202885 Ramp1 -0,58 7,58E-04 Development and Disease
213956 9930022N03Rik -0,58 8,07E-04 Unknown (expressed in dendtritic cells)
253726 Synaptotagmin11 -0,56 1,77E-03 Synaptic vesicle trafficking, Nervous system 
function, Response to oxidative stress
218976 4833414E09Rik -0,55 3,39E-03 Unknown (expressed in skin and neonate 
head)
273728 Zbtb33 -0,55 3,81E-03 DNA replication, Nervous System 
Development and Function
277491 Adam24 -0,54 5,33E-03 Reproductive System Development and 
Function
300948 4930579C12Rik -0,54 5,41E-03 Unknown (Reproductive system)
207253 C330013F16Rik -0,54 7,11E-03 Unknown
279418 A530088H08Rik -0,53 8,21E-03 Unknown
287029 Fryl -0,53 9,99E-03 Cardiovascular Disease, Cellular 
Development, Embryonic Development
287258 Grin1 -0,52 1,26E-02 Carbohydrate metabolism, Lipid 
metabolism, Small molecule Biochemistry
312507 9030411K21Rik -0,51 2,50E-02 Unknown (Embryonic Development)
192336 BC043118 -0,50 3,79E-02 Unknown (Nervous System Development)
217372 Sec1 0,50 3,28E-02 Synaptic transmission and general 
secretion
241944 2810471M01Rik 0,51 2,15E-02 Unknown
214574 Cabp1 0,52 1,61E-02 Calcium transport, Response to oxidative 
stress
248843 T2bp 0,52 1,32E-02 Cell DeathChadi et al. BMC Genomics 2010, 11:448
http://www.biomedcentral.com/1471-2164/11/448
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240393 Nfe2 0,53 1,00E-02 DNA replication, Nervous System 
Development and Function
305580 Abcc12 0,53 9,52E-03 Cardiovascular Disease, Cellular 
Development, Embryonic Development
253103 Adck4 0,53 9,28E-03 Cardiovascular Disease, Cellular 
Development, Embryonic Development
235246 Cyp2d26 0,54 5,56E-03 Detoxification, Clearance of drugs
200884 Sall3 0,54 5,56E-03 Cancer, Cell growth and proliferation, 
Respiratory Disease
235326 Kcnj5 0,54 4,30E-03 Cell Death, Neurological Disease, Nervous 
System Development and Disease
187962 1700055C04Rik 0,56 2,11E-03 Unknown (Reproductive system)
310508 Arfgef2 0,56 1,79E-03 Cardiovascular Disease, Cellular 
Development, Embryonic Development
271541 Dusp4 0,56 1,56E-03 Carbohydrate metabolism, Lipid 
metabolism, Small molecule Biochemistry
189538 Hist2h3c1 0,57 1,29E-03 DNA replication, Nervous System 
Development and Function
192597 Grit 0,58 6,36E-04 Neural Development
273128 Nrbp2 0,59 2,86E-04 Embryonic mouse brain development, 
Neuronal differentiation
259059 Ralb 0,62 6,20E-05 Carbohydrate metabolism, Lipid 
metabolism, Small molecule Biochemistry
194060 Defb13 0,65 1,47E-05 Host's innate defense
197262 Sprr2g 0,67 3,88E-06 Cell Death, Neurological Disease, Nervous 
System Development and Disease
278391 1110038D17Rik 0,79 8,61E-10 Unknown (Embryonic Development)
284995 GeneBank A530045M11, 
AI604229, AA174363
0,81 1,62E-10 Unknown
Differentially expressed genes detected by the microarray analysis are listed with the calculated differential ratios (log2) and the Bonferroni 
p values (Bonf Pval). The top functions were deduced either using the Ingenuity pathways analysis software http://www.ingenuity.com or by 
looking at the expression pattern and putative functions attributed to those genes (italized annotations). Italic names: genes potentially 
involved in cellular development and differentiation. Bold-faced type name: gene potentially involved in cell death and disorders, including 
response to oxidative stress. Italic and bold-faced type names: genes potentially involved in both sets of functions.
Table 4: Differentially expressed genes detected at 14 weeks by microarray studies comparing Tg37+/- NFH-Cre-/- and 
Tg37+/- NFH-Cre+/- brain tissues. (Continued)
(Table 3 and [5,6]). At 14 weeks, the differentially
expressed genes are rather evocative of a remodeling of
the nervous system (Table 4). Most of the identified genes
are indeed involved in cellular development and neuronal
differentiation. The stage-specific modulation of the
Kcnj5 and Synaptotagmin II are in agreement with this
proposed scenario. So although a few genes are found to
be differentially expressed with low detected log ratios,
the functions of these genes appear relevant and consis-
tent.
Overall, our data suggest that invalidation of the Prnp
gene does not induce gross modification of the adult
mouse brain transcriptome. When this event happens a
f e w  d a y s  b e f o r e  t h e  a n a l y s i s  i s  p e r f o r m e d ,  w e  c a n n o t
however exclude that the few moderately differentially
expressed genes that are then detected indicate a physio-
logical PrP role in adult neuronal homeostasis, synaptic
transmission, survival and differentiation. Several
hypotheses might explain this unexpected low respon-
siveness to the invalidation of such an evolutionary con-
served protein at least in mammals. An explanation
might be that the cellular response to the lack of PrP does
not involve transcriptomic alteration but modifications of
post-transcriptomic regulations. This latter suggestion is
attractive in regards with the recently published miRNA
specific signature observed in mouse-scrapie affected
brains [34]. However, it is in contradiction with the lack
of detectable modification of the brain proteome of Prnp-
/- mice [29], which could rather suggest that the variations
observed in the miRNA profile is a consequence of the
scrapie infection rather than of a PrP loss of function. It is
also possible that the overall brain lack of response is dueChadi et al. BMC Genomics 2010, 11:448
http://www.biomedcentral.com/1471-2164/11/448
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to the fact that the invalidation of the Prnp gene only
affects a small subset of the brain cellular population and
is therefore not detectable in our present transcriptomic
analysis or in the proteomic experiment of Crecelius et al.
[29]. Indeed, if as suggested PrP positively regulates neu-
ral precursor proliferation in adult [35], the effect of its
invalidation might be difficult to assess without prior
purification of this cell type. PrP might also be essential
for brain response to specific stressful physiological con-
ditions and that the physiological role of this gene was
therefore not challenged in the classical presently used
breeding conditions. Another attractive explanation
would be that PrP has a key function only during early
embryogenesis, as its developmental regulation [7-9] and
recently published experimental data involving gene
knockdowns [36,37] suggest. Following this early devel-
opmental stage, the physiological role of PrP might be
less crucial and/or redundant under normal physiological
conditions. If so, it would be important to repeat tran-
scriptomic and proteomic analyses at earlier embryonic
stages, at the time Prnp is turned on or under specific
breeding conditions.
Conclusions
This paper documents the lack of drastic brain transcrip-
tomic modification following the Prnp invalidation either
at the zygotic stage or in adult neuronal cells of the brain
tissue. It is consistent with the recently reported pro-
teomic stability of the brain of such PrP-knockout mice
[29] and questions some of the obtained results using in
vitro cell cultures [25-27]. It might suggest that either this
gene knockdown affects the animal physiology at a differ-
ent developmental stage than the one studied here or that
it has to be analyzed in certain particular environmental
conditions and/or in more specific cell types.
Methods
Mouse brain material and DNA or RNA extraction
Mouse brains from five 6 weeks old female FVB/N and
FVB/N Prnp -/- animals [10,30] were collected and frozen
in liquid nitrogen immediately after decapitation.
Homozygous Tg37 mice were crossed with heterozygous
NFH-Cre (Cre 22) mice and the genotype of the resulting
pups determined by PCR analysis of their tail-extracted
genomic DNA as previously described [14]. Sets of two
males and two females of Tg37+/- NFH-Cre+/- or of Tg37+/
- NFH-Cre-/- genotype, respectively, and of either 10 or 14
weeks old were obtained and their brains collected and
frozen in liquid nitrogen immediately after decapitation.
All animal manipulations were done according to the rec-
ommendations of the French Commission de Génie Gén-
étique.
Table 5: QPCR analysis of the expression of candidate genes resulting from microarray studies comparing Tg37xNFH-Cre 
versus Tg37 mice.
Genes Tg37xNFH-Cre Tg37xNFH-Cre
Microarray QPCR Protein
(log2 ratio) (ΔΔ CT)
10 weeks
Glrx3 -0.6 0.34 glutaredoxin 3
Atp13a1 0.81 -0.08 ATPase type 13A1
Prnp Tg37 ND -5.62 Prion protein
14 weeks
AV451297.1 -2.62 -0.02 Hypothetical protein
Ifitm3 -1.41 -0.12 Interferon-induced transmembrane protein 3
Erf1 -1.19 -1.12 Eukaryote class I release factor
Bace1 -0.48 -0.02 beta-site APP-cleaving enzyme 1
BB217622.2 0.81 0.64 Unknown
Riken D17 0.79 0.31 Unknown
Fgf2 0.48 0.47 fibroblast growth factor 2
Prnp Tg37 ND -6.43 Prion protein
Differentially expressed genes detected by the microarray analysis are listed with the calculated differential ratio (log2) alongside the 
observed delta-delta CT resulting from the QPCR experiment. The comparative Ct method is known as the 2 - [delta][delta]Ct method, where delta 
delta Ct = [delta]Ct, sample - [delta]Ct, reference. Age of the analyzed mice is mentioned.Chadi et al. BMC Genomics 2010, 11:448
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RNA extractions for the microarray were made using
the RNeasy Lipid Tissue Midi kit (Qiagen cat no. 75842).
Each brain sample was treated independently. RNA con-
centration was calculated by electro-spectrophotometry
and the RNA integrity checked with the Agilent Bioanaly-
ser (Waldbroom, Germany). Pools were obtained by mix-
ing equal amounts of total RNA from each individual
sample.
Microarray analysis
Microarray analysis was carried out at the Unité de
Recherche en Génomique Végétale (URGV, Evry, France)
using the mouse 25K array [38] containing 24109 mouse
gene-specific oligonucleotides. Amplified RNAs were
produced from 2 μg of total RNA from each pool with the
"Amino Allyl Message Amp aRNA amplification kit"
(Ambion). Five g of amplified RNAs were reversed tran-
scribed with SuperScript II Reverse Transcriptase kit
(Invitrogen) in the presence of cy3-dUTP or cy5-dUTP
for each slide as previously described [39]. Hybridiza-
tions, array scanning and image analyses were performed
as previously described [40], using a GenePix 4200A
scanner and GenePix Pro 3.0 (Axon Instruments).
The statistical analysis was based on two dye-swap. For
each array, the raw data comprised the logarithm of
median feature pixel intensity at wavelengths 635 nm
(red) and 532 nm (green). No background was sub-
tracted. In the following description, log-ratio refers to
the differential expression between the two tissues ana-
lyzed: either log2 (red/green) or log2 (green/red), accord-
ing to the experimental design. An array-by-array
normalization was performed to remove systematic
biases. First, features that were considered by the experi-
menter to be badly formed (e.g. because of dust) were
excluded (flagged) 100 in the GENEPIX software. Then
we performed a global intensity-dependent normaliza-
tion using the Loess procedure [41] to correct the dye
bias. Finally, on each block the log-ratio median was sub-
tracted from each value of the log-ratio of the block to
correct a print-tip effect.
To determine differentially expressed genes, we per-
formed a paired t-test. We assumed that the variance of
the log-ratios was the same for all genes, by calculating
the average of the gene-specific variance. In order to
assess this assumption, we excluded spots with a variance
too small or too large. Raw P-values were adjusted by the
Bonferroni method, which controls the family-wise error
rate [42]. A gene is declared differentially expressed if its
adjusted P-value is lower than 0.05. The statistical analy-
sis was performed by using the package R anapuce http://
www.agroparistech.fr/mia/doku.php?id=produc-
tions:logiciels#anapuce1.1.
QPCR analysis
Three μg of purified RNA was reverse transcribed with
SuperScript II Reverse Transcriptase kit (Invitrogen)
according to the manufacturer's protocol. Quantitative
real-time PCR analysis was performed using ABI PRISM
7000 Sequence Detection System (Applied Biosystems)
and SYBR Green (Applied Biosystems). Primers used are
Table 6: List of the used oligonucleotides
FVB/N PrP-/- mice
Name SEQUENCE (5' -3')
Prnp 5' CAACCGAGCTGAAGCATTCTG
Prnp 3' CGACATCAGTCCACATAGTC
scg5 5' CCTTTATGAGAAAATGAAGGG
scg5 3' GGACAGATTTCTTTGCCACA
Tg37xNFH-Cre mice
Name SEQUENCE (5' -3')
Ifitm3 5' TCAGCATCCTGATGGTTGTT
Ifitm3 3' TGTTACACCTGCGTGTAGGG
AV451297.1 5' CCCGAAGCGTTTACTTTGAA
AV451297.1 3' CCCTCTTAATCATGGCCTCA
Erf1 5' TCGCTCCACCAACTAAGAAC
Erf1 3' AAACACGGGAAACCTCACC
Prnp Tg37 5' GAAGGAGTCCCAGGCCTATT
Prnp Tg37 3' GCAGGAATGAGACACCACCT
Glrx3 5' CATAAGCATGGTGTCCAAGG
Glrx3 3' TGCCTTCTCTGCTTCGTAGA
Riken D17 5' AAGCCTTCATAGCGAGTGGA
Riken D17 3' TTCCAGACAAGTGGACCTGA
Bace1 5' TCGACCACTCGCTATACACG
Bace1 3' CTCCTTGCAGTCCATCTTGAG
Fgf2 B 5' AGCGGCTCTACTGCAAGAAC
Fgf2 B 3' GCCGTCCATCTTCCTTCATA
Atp13a1 5' CGTGACAAGGGTGAAGATGG
Atp13a1 3' ATAGTAAGAGAAGGCATTCC
BB217622.2 5' CCAGTTCCGTCAAAGTACCC
BB217622.2 3' CATGCAGATCTTCAGGTCCA
β-actin 5' TGTTACCAACTGGGACGACA
β-actin 3' GGGGTGTTGAAGGTCTCAAA
The sequences of the oligonucleotides used in the QPCR 
experiments are listed; including those of the housekeeping 
gene that was used in the three described analyses. The sets of 
primers for the Erf1, Glrx3, BB217622.2 and the AV451297.1 loci 
were designed within a single exon. All the other sets were 
designed over exon-exon borders.Chadi et al. BMC Genomics 2010, 11:448
http://www.biomedcentral.com/1471-2164/11/448
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listed in Table 6. These primers were designed over exon-
exon borders if possible. If not, a RT - control was added
in the experiment to control for the absence of DNA con-
taminant. Normalization was done using the β-actin
housekeeping gene. The temperature cycle used com-
prised 45 cycles at 95°C for 15 sec and 60°C for 1 min. A
dissociation curve followed, this was comprised of 95°C
for 15 sec, 60°C for 1 min and 95°C for 10 sec. Each sam-
ple was analysed in triplicate and data analysed using the
Delta-Delta Ct method.
Scg5 promoter analysis
Genomic DNA was extracted from tail biopsies as previ-
ously described [43]. The Scg5 proximal promoter was
amplified by PCR using the set of primers 5'-CCAG-
GAATCTCCTAAGATCCTGG-3' and 5'-GACATC-
CTCTAGATTTTAGAATTACC-3' [33]. The amplified
DNA fragment was gel purified and sequenced [44].
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